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Abstract  
We report two cases of systemic sarcoidosis with atrial flutter as the clinical manifestation. In 
one patient, who had symptoms of shorter duration, the arrhythmia was no longer inducible 
after a course of glucocorticoid therapy. Electroanatomical mapping in the other case revealed 
patchy  fibrosis  of  the  left  atrial  myocardium  and  multiple  macro-reentrant  circuits.  Sinus 
rhythm could be restored with ablation of these reentrant circuits. To our knowledge, this is the 
first  report  on the  demonstration  of  atrial  scarring in  a  patient  with  sarcoidosis  using 3-D 
electroanatomical  mapping.  These  two  cases  illustrate  that  the  inflammation  of  atrial 
myocardium  is  the  primary  mechanism  of  atrial  arrhythmias  in  patients  with  cardiac 
sarcoidosis.
Introduction
Sarcoidosis is a systemic granulomatous disease of unknown etiology,  with clinical cardiac 
involvement varying from 20 to 60% of patients [1,2], most often manifesting as abnormalities 
in  the  conduction  or  with  pericardial  involvement.  Atrial  arrhythmia  or  granulomatous 
involvement of the atrial myocardium has rarely been described in them [2,3]. Here we report 2 
patients  who  presented  with  atrial  arrhythmias  as  the  isolated  cardiac  manifestation  of 
sarcoidosis.  Based  on  the  findings  on  electrophysiological  (EP)  study  including  3-D 
electroanaomical  mapping,  we  propose  evidence  for  direct  involvement  of  the  atrial 
myocardium in  the form of  inflammation  and scarring  in  cardiac  sarcoidosis,  which  could 
guide the therapeutic approach in these patients.                                                      
Case  1                                                    
A 49-year-old  male,  with  a  permanent  pacemaker  implanted  for  complete  heart  block  and 
history of iritis a few months before, presented with recurrent episodes of palpitation over the 
preceding few weeks. The 12-lead electrocardiogram was suggestive of atypical atrial flutter of 
probable left atrial origin (Figure 1). The echocardiogram was normal except for mildly dilated 
atria.  There  was  no  history  of  hypertension,  diabetes  or  dyslipidemia.  A  computerized 
tomographic (CT) scan of the thorax done to define atrial anatomy prior to ablation showed 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 12 (6): 284-289 (2012)
This is an open access article under the CC BY-NC-ND license.
Namboodiri N et al, “EP Features of Atrial Flutter in Cardiac Sarcoidosis”                      285
multiple nodules in the lung parenchyma, which on transbronchial lung biopsy was suggestive 
of sarcoidosis.  An elective EP study was planned, and in the meantime he was treated with 
prednisolone 1mg/kg/day and sotalol 40 mg/day. Atrial flutter could not be induced during EP 
study performed after 2 months of steroid therapy. He remained asymptomatic thereafter, and 
device  interrogation  till  24  months  after  EP  study  revealed  only  a  few  episodes  of  non-
sustained atrial tachycardia.
Figure 1: ECG of  flutter  in  case  1.  The morphology of  flutter  waves  suggests  a  left  atrial  origin.  Note the 
intraventricular  conduction  defect  also.                                           
Case  2                                        
A 48-year-old woman was referred to us with recurrent episodes of paroxysmal atrial flutter, 
treated with a failed attempt at ablation and pharmacotherapy (flecainide, sotalol and atenolol) 
in the past.  Chest X-ray followed by CT scan of the thorax suggested type III  pulmonary 
sarcoidosis with extensive involvement of the lung parenchyma.  Echocardiography showed a 
mildly dilated left ventricle (LV) and left atrium (LA, anteroposterior diameter of 45 mm) with 
normal  LV  systolic  function.  Electrocardiogram  suggested  LA  flutter  with  varying 
atrioventricular conduction (Figure 2). After treatment with prednisolone (1 mg/kg/day) for 6 
weeks,  she  was  taken  for  EP  study.  Atrial  flutter  (cycle  length  of  212  ms)  could  not  be 
entrained from right atrium, with postpacing interval (PPI) exceeding tachycardia cycle length 
(TCL)  by more  than  50 ms.  Voltage  mapping  of  the  LA performed with  CARTO system 
(Biosense-Webster), with scar defined as the absence of recordable activity or a bipolar voltage 
amplitude ≤ 0.05 mV, suggested extensive scarring of the posterior LA wall (Figure 3). The 
tachycardia could be entrained from lateral mitral isthmus (PPI – TCL = 30 ms). Ablation of 
the lateral mitral isthmus was performed using an externally irrigated catheter (Thermocool, 
Biosense-Webster, 35 W), resulted in continuation of flutter with prolongation of TCL by 10ms 
(Figure 4). Assuming incomplete block, an anterior mitral isthmus line was attempted joining 
the anterior scar to the mitral annulus (Figure 5). This resulted in an abrupt prolongation of the 
TCL to 258 ms (Figure 5). Repeat mapping of the atria demonstrated dissociated activity in the 
LA appendage  confirmed the  complete  block at  both  these  ablation  lines  with  inadvertent 
isolation  of  the  lateral  left  atrium  (Figure  6).  The  slower  flutter  was  confirmed  to  be 
cavotricuspid isthmus dependent (Figure 7; PPI - TCL = 10 msec). The flutter terminated on 
ablation of cavotricuspid isthmus. The endpoint was bidirectional block on established criteria. 
The patient has remained in sinus rhythm after 30 months of follow up.
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 12 (6): 284-289 (2012)
Namboodiri N et al, “EP Features of Atrial Flutter in Cardiac Sarcoidosis”                      286
Figure 2: ECG of flutter in case 2. 
Figure 3: Electroanatomic map of the left atrium during flutter presented in Figure 2. A large area of scar is noted 
along the posterior left atrium. Activation mapping demonstrates a counter-clockwise peri-mitral macro-reentry. 
Entrainment  demonstrates  the  best  post  pacing  interval  (PPI)  at  the  lateral  mitral  isthmus.
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Figure 4: Subtle change in morphology and tachycardia cycle length (TCL) with lateral mitral isthmus ablation.
Figure 5:  Further change in tachycardia cycle length (TCL) and morphology with anterior mitral isthmus line.
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Figure 6: Inadvertent  isolation of the entire lateral  left atrium. Note the electrogram insert shows dissociated 
activity  (red  circles)  within  the  left  atrium.                                           
Figure 7: Repeat mapping demonstrates typical cavotricuspid isthmus dependent macro-reentry.
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Discussion
The tissue changes in sarcoidosis are characterized by accumulation of T lymphocytes  and 
mononuclear phagocytes, non-caseating epithelioid granulomas, and derangements of normal 
tissue  architecture,  all  leading  to  parenchymal  damage  and  irreversible  tissue  fibrosis  [3]. 
Granulomatous lesions in sarcoidosis are known to occur in endocardium, pericardium and 
ventricular myocardium, the latter being the most common site. In a necropsy study in 113 
patients with cardiac sarcoidosis, Roberts et al noted extensive ventricular scarring as a result 
of healing of granulomas in all [4]. However, only 2 of them had granulomas in atrial walls. 
Atrial  arrhythmia  as  the  sole  cardiac  clinical  manifestation  of  sarcoidosis  has  not  been 
described  thus  far  in  the  literature.                                                 
The development of atrial or ventricular arrhythmias can result in significant hemodynamic and 
clinical deterioration in these patients with a high incidence of co-existing systolic or diastolic 
dysfunction.  The mechanism for ventricular tachyarrhythmias is thought to be mediated via 
granulomas and myocardial fibrosis, while atrioventricular block occurs presumably secondary 
to nodal artery ischemia or granulomas in the basal septum. Atrial arrhythmia in sarcoidosis, a 
less well-characterized entity, was proposed to be more due to atrial dilatation secondary to 
ventricular,  valvular  or pulmonary involvement  rather  than direct  involvement  of the atrial 
myocardium  [3].  Our  patients  had  neither  the  involvement  of  these  structures  on 
echocardiography  nor  any  systemic  risk  factors  known  to  result  in  atrial  arrhythmias.  In 
addition, the response to anti-inflammatory drugs in the early stage of cardiac involvement in 
the first case and the demonstration of extensive scarring of atrial wall in the second, clearly 
suggest a stage of active inflammation followed by the development of fibrosis and scarring of 
atrial  myocardium  in  the  natural  history  of  cardiac  sarcoidosis.  We  could  not  have  a 
histological evidence to support this as the biopsy of atrial myocardium was not attempted due 
to  ethical  and  safety  reasons.                                              
To our knowledge, this is the first report on the demonstration of atrial scarring in a patient 
with sarcoidosis by voltage mapping using any 3-D electroanatomical mapping system. Our 
index patient had no other risk factors which could otherwise account for the scarring of the LA 
myocardium. The EP findings in this case suggest that the atrial myocardium can be directly 
involved in sarcoidosis resulting in patchy areas of scarring interspersed with conducting atrial 
myocardium, an ideal substrate for multiple macro-reentrant circuits. Recognition and ablation 
of  these  circuits  can  result  in  long-term  maintenance  of  sinus  rhythm in  these  patients.  
Reference  
1. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 
unselected  patients  with  systemic  sarcoidosis.  Circulation.  1978;  58:1204-11.           
2.  Matsui  Y,  Iwai  K,  Tachibana  T,  et  al.  Clinicopathological  study  of  fatal  myocardial 
sarcoidosis. Ann N Y Acad Sci. 1976; 278:455-69.                                          
3. Habersberger J, Manins V, Taylor AJ. Cardiac sarcoidosis. Intern Med J. 2008; 38:270-7.  
4. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic 
study  of  35  necropsy  patients  (group  1)  and  review  of  78  previously  described  necropsy 
patients (group 11). Am J Med. 1977;63:86-108.
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 12 (6): 284-289 (2012)
